查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539332

軟膠囊市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033

Softgel Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份有關全球軟膠囊市場的詳細報告。本報告對驅動因素、趨勢、機會和挑戰等關鍵市場動態進行了全面分析，提供了對市場結構的深入見解。

關鍵見解

  • 軟膠囊市場規模（2024年）：6.381億美元
  • 市場預測金額（2033年）：9.321億美元
  • 全球市場成長率（2024-2033年年複合成長率）：4.3%

軟膠囊市場：研究範圍

軟膠囊市場包括主要用於製藥、營養品和化妝品行業的各種產品。這些膠囊提供了一種方便有效的方式來傳遞多種活性成分，包括維生素、礦物質、植物藥和藥物。軟膠囊因其易於吞嚥的形狀、更高的生物利用度以及封裝液體或半液體成分的能力而受到青睞。該市場服務於製藥公司、營養補充劑製造商和化妝品製造商等不同領域。消費者對膠囊產品的偏好不斷增加、膠囊製造技術的進步以及軟膠囊在各種治療和飲食領域的應用不斷擴大，推動了成長。

推動市場成長的因素：

幾個關鍵因素推動全球軟膠囊市場的發展。消費者對營養保健品和營養保健品的需求不斷成長，推動了對有效封裝技術的需求，導致軟膠囊的採用增加。膠囊製造的技術進步，例如改進的封裝過程和增強的殼配方，進一步推動了市場的擴張。此外，人們越來越認識到軟膠囊在提高生物利用度和患者依從性方面的優勢，也推動了製藥業的需求。透過引進創新膠囊配方，加強研發活動，為各種消費者需求提供更好的解決方案，進而促進市場成長。

市場限制因素：

儘管預計軟膠囊市場將迎來良好的成長，但其面臨著與先進封裝技術相關的高製造成本以及軟膠囊配方中某些活性成分的潛在不穩定性所帶來的挑戰。此外，片劑和硬膠囊等替代劑型的出現也可能阻礙市場成長。片劑和硬膠囊可能因其成本較低和保存期限較長而受到一些消費者的青睞。此外，軟膠囊審批和標籤方面的監管挑戰也對市場擴張構成障礙。應對這些挑戰需要持續投資研發，以提高配方穩定性、降低製造成本並應對複雜的監管環境。

市場機會：

在個人化營養的日益普及以及製藥業對創新輸送形式的需求不斷成長的推動下，該市場提供了巨大的商機。先進軟膠囊的開發，例如腸溶衣和控釋特性，滿足了對更有效和更有針對性的遞送系統日益成長的需求。電子商務平台和線上補充劑商店的擴張為市場成長提供了新的管道，並使公司能夠為更多人提供方便的軟膠囊獲取途徑。策略合作夥伴關係、新技術投資和組合膠囊的採用對於利用新機會和維持市場領先地位非常重要。

報告回答的關鍵問題

  • 推動全球軟膠囊市場成長的關鍵因素是什麼？
  • 哪些類型和應用的軟膠囊在各種環境中處於領先地位？
  • 技術進步如何影響軟膠囊市場的競爭格局？
  • 誰是軟膠囊市場的主要參與者？
  • 全球軟膠囊市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第4章 關鍵成功因素

  • 產品採用/使用分析
  • 產品 USP/特點

第5章 全球市場需求分析

  • 2019-2023年過去的市場量（百萬單位）分析
  • 2024-2033年當前及未來市場容量（百萬單位）預測
  • 年成長趨勢分析

第6章 世界市場 - 價格分析

  • 區域價格趨勢分析
  • 世界平均價格分析基準

第7章 全球市場需求（金額或規模，百萬美元）分析

  • 2019-2023年過去的市值（百萬美元）分析
  • 2024-2033年當前及未來市場價值（百萬美元）預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第8章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 價值鏈
  • 全球營養補充品產業展望
  • 全球營養保健品產業的前景
  • 市場動態
  • 世界供需分析

第9章 政策制定與監管情境

第10章 全球市場分析：依產品類型

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）與的數量分析：依產品類型
  • 2024-2033年當前和未來市場規模（百萬美元）以及的數量分析和預測：依產品類型
    • 明膠軟膠囊
    • 素食軟膠囊
  • 市場吸引力分析：依產品類型

第11章 世界市場分析：依原料分類

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）及數量分析：依原料
  • 2024-2033年當前和未來市場規模（百萬美元）以及數量分析和預測：依原料
    • 魚骨明膠
    • 羥丙基甲基纖維素（HPMC）
    • 普魯蘭多醣
    • 澱粉類物質
    • A型明膠（豬皮）
    • B 型明膠（動物骨頭和小牛皮）
  • 市場吸引力分析：依原料分類

第12章 世界市場分析：依最終使用者

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）與數量分析：依最終用戶
  • 當前和未來市場規模（百萬美元）以及數量分析和預測，2024-2033年：依最終用戶
    • 合約製造組織
    • 化妝品公司
    • 營養食品公司
    • 製藥公司
  • 市場吸引力分析：依最終用戶分類

第13章 世界市場分析：依應用

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）與數量分析：依應用
  • 2024-2033年當前和未來的市場規模（百萬美元）以及數量分析和預測：依應用
    • 抗酸劑/腸道調節劑
    • 抗貧血劑（造血劑）
    • 抗生素/抗菌藥物
    • 抗發炎藥
    • 心血管藥物
    • 咳嗽和感冒措施
    • 保健品
    • 維生素/營養補充劑
    • 其他治療用途
  • 市場吸引力分析：依應用分類

第14章 世界市場分析：依地區

  • 簡介
  • 2019-2023年歷史市場規模（百萬美元）與數量分析：依地區
  • 2024-2033年當前市場規模（百萬美元）及數量分析及預測：依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞/太平洋地區
    • 中東和非洲（MEA）
  • 市場吸引力分析：依地區劃分

第15章 北美市場分析

第16章 拉丁美洲市場分析

第17章 歐洲市場分析

第18章 南亞/太平洋市場分析

第19章 東亞市場分析

第20章 中東、非洲市場分析

第21章 2024年各國軟膠囊市場分析

  • 簡介
  • 美國市場分析
  • 加拿大市場分析
  • 墨西哥市場分析
  • 巴西市場分析
  • 德國市場分析
  • 義大利市場分析
  • 法國市場分析
  • 英國市場分析
  • 西班牙市場分析
  • 俄羅斯市場分析
  • 波蘭市場分析
  • 中國市場分析
  • 日本市場分析
  • 韓國市場分析
  • 印度市場分析
  • 南非市場分析

第22章 市場結構分析

  • 市場分析：依公司層級（軟膠囊）
  • 主要公司市佔率分析
  • 市場現況分析

第23章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳情
    • Aenova Group GmbH
    • Capsugel
    • Guangdong Yichao Biological Co., Ltd.
    • Elnova Pharma
    • Hunan Er-Kang Pharmaceutical Co., Ltd
    • Catalent, Inc
    • Soft Gel Technologies, Inc
    • Renown Pharmaceuticals
    • MEDGEL
    • Celix Pharma
    • Roquette
    • HC Clover PS
    • BIONOMICS LIFESCIENCES PVT. LTD.
    • Medi-Caps Group
    • 其他（依額外要求）

第24章 使用的先決條件與縮寫

第25章 研究方法

簡介目錄
Product Code: PMRREP14608

Persistence Market Research has recently published an extensive report on the global Softgel Capsules Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Softgel Capsules Market Size (2024E): USD 638.1 Mn
  • Projected Market Value (2033F): USD 932.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.3%

Softgel Capsules Market - Report Scope:

The Softgel Capsules Market encompasses a variety of products primarily used in the pharmaceutical, nutraceutical, and cosmeceutical industries. These capsules offer a convenient and efficient way to deliver a wide range of active ingredients, including vitamins, minerals, botanicals, and pharmaceutical drugs. Softgel capsules are favored for their easy-to-swallow form, increased bioavailability, and ability to encapsulate liquid or semi-liquid ingredients. The market serves diverse segments, including pharmaceutical companies, dietary supplement manufacturers, and cosmetic product companies. Growth is driven by increasing consumer preference for encapsulated products, advancements in capsule manufacturing technologies, and the expanding application of softgel capsules across various therapeutic and dietary segments.

Market Growth Drivers:

Several key factors are driving the global Softgel Capsules Market. The rising consumer demand for dietary supplements and nutraceuticals boosts the need for effective encapsulation technologies, leading to the increased adoption of softgel capsules. Technological advancements in capsule manufacturing, such as improved encapsulation processes and enhanced shell formulations, further fuel the market's expansion. Additionally, the growing awareness of the benefits of softgel capsules in terms of improved bioavailability and patient compliance drives demand in the pharmaceutical industry. Enhanced research and development activities, along with the introduction of innovative capsule formulations, contribute to market growth by offering more tailored solutions for various consumer needs.

Market Restraints:

Despite promising growth prospects, the Softgel Capsules Market faces challenges related to the high production costs associated with advanced encapsulation technologies and the potential instability of certain active ingredients within softgel formulations. Market growth can be hindered by the availability of alternative delivery forms, such as tablets and hard capsules, which may be preferred by some consumers due to their lower cost and longer shelf life. Additionally, regulatory challenges related to the approval and labeling of softgel capsules pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve formulation stability, reduce production costs, and navigate complex regulatory landscapes.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of personalized nutrition and the rising demand for innovative delivery forms in the pharmaceutical industry. The development of advanced softgel capsules, such as those with enteric coatings or controlled-release properties, caters to the growing need for more effective and targeted delivery systems. The expansion of e-commerce platforms and online supplement stores provides new channels for market growth, allowing companies to reach a broader audience and offer convenient access to softgel capsules. Strategic partnerships, investments in new technologies, and the introduction of combination capsules are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Softgel Capsules Market globally?
  • Which types and applications of softgel capsules are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the Softgel Capsules Market?
  • Who are the key players in the Softgel Capsules Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Softgel Capsules Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Softgel Capsules Market, including Catalent, Inc., Aenova Group, and Capsugel (a Lonza company), focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced softgel capsule solutions and explore new therapeutic applications. Collaborations with pharmaceutical companies, dietary supplement manufacturers, and research organizations facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Softgel Capsules Market landscape.

Key Companies Profiled:

  • Aenova Group GmbH
  • Capsugel
  • Guangdong Yichao Biological Co., Ltd.
  • Elnova Pharma
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Catalent, Inc
  • Soft Gel Technologies, Inc
  • Renown Pharmaceuticals
  • MEDGEL
  • Celix Pharma
  • Roquette
  • HC Clover PS
  • BIONOMICS LIFESCIENCES PVT. LTD.
  • Medi-Caps Group
  • Others (on additional request)

Softgel Capsules Market Industry Segmentation:

By Product Type:

  • Gelatin Softgel Capsules
  • Vegetarian Softgel Capsules

By Raw Material:

  • Type-A Gelatin (Pork Skin)
  • Type-B Gelatin (Animal Bones & Calf Skin)
  • Fish Bone Gelatin
  • Hydroxy Propyl Methyl Cellulose (HPMC)
  • Starch Material
  • Pullulan

By End User:

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmecutical Companies
  • Contract Manufacturing Organizations

By Application:

  • Antacid & Antiflatulent Preparations
  • Antianemic Preparations (Hematenic Preparations)
  • Anti-inflammatory Drugs
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Preparations
  • Cardiovascular Therapy Drugs
  • Health Supplements
  • Vitamin & Dietary Supplements
  • Other Therapeutic Applications

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features

5. Global Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 5.1. Historical Market Volume (Mn Units) Analysis, 2019-2023
  • 5.2. Current and Future Market Volume (Mn Units) Projections, 2024-2033
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global Market - Pricing Analysis

  • 6.1. Regional Pricing Trend Analysis
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Global Food Industry Overview
    • 8.1.3. Global GDP and Infrastructure Investment
    • 8.1.4. International Trade
    • 8.1.5. Global Industry Outlook
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Top Companies Historical Growth
    • 8.2.2. GDP Growth forecast
    • 8.2.3. Manufacturing Industry forecast
    • 8.2.4. Business Climate
  • 8.3. Value Chain
    • 8.3.1. Raw Material Suppliers
    • 8.3.2. Product Manufacturers
    • 8.3.3. End Users
  • 8.4. Global Dietary Supplement Industry Outlook
  • 8.5. Global Nutraceutical Industry Outlook
  • 8.6. Market Dynamics
    • 8.6.1. Drivers
    • 8.6.2. Restraints
    • 8.6.3. Opportunity Analysis
  • 8.7. Global Supply Demand Analysis

9. Policy Developments and Regulatory Scenario

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
    • 10.3.1. Gelatin Softgel Capsules
    • 10.3.2. Vegetarian Softgel Capsules
  • 10.4. Market Attractiveness Analysis By Product Type

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Raw Material

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Raw Material, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Raw Material, 2024-2033
    • 11.3.1. Fish Bone Gelatin
    • 11.3.2. Hydroxyl Propyl Methyl Cellulose (HPMC)
    • 11.3.3. Pullulan
    • 11.3.4. Starch Material
    • 11.3.5. Type-A Gelatin (Pork Skin)
    • 11.3.6. Type-B Gelatin (Animal Bones & Calf Skin)
  • 11.4. Market Attractiveness Analysis By Raw Material

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Contract Manufacturing Organizations
    • 12.3.2. Cosmeceutical Companies
    • 12.3.3. Nutraceutical Companies
    • 12.3.4. Pharmaceutical Companies
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2024-2033
    • 13.3.1. Antacid & Antiflatulent Preparations
    • 13.3.2. Antianemic Preparations (Hematenic Preparations)
    • 13.3.3. Antibiotic & Antibacterial Drugs
    • 13.3.4. Anti-inflammatory Drugs
    • 13.3.5. Cardiovascular Therapy Drugs
    • 13.3.6. Cough & Cold Preparations
    • 13.3.7. Health Supplement
    • 13.3.8. Vitamin & Dietary Supplements
    • 13.3.9. Other Therapeutic Applications
  • 13.4. Market Attractiveness Analysis By Application

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. East Asia
    • 14.3.5. South Asia and Pacific
    • 14.3.6. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Product Type
    • 15.3.3. By Raw Material
    • 15.3.4. By End User
    • 15.3.5. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product Type
    • 15.4.3. By Raw Material
    • 15.4.4. By End User
    • 15.4.5. By Application
  • 15.5. Drivers and Restraints - Impact Analysis

16. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Product Type
    • 16.3.3. By Raw Material
    • 16.3.4. By End User
    • 16.3.5. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product Type
    • 16.4.3. By Raw Material
    • 16.4.4. By End User
    • 16.4.5. By Application
  • 16.5. Drivers and Restraints - Impact Analysis

17. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Nordic
      • 17.3.1.8. Russia
      • 17.3.1.9. Poland
      • 17.3.1.10. Rest of Europe
    • 17.3.2. By Product Type
    • 17.3.3. By Raw Material
    • 17.3.4. By End User
    • 17.3.5. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product Type
    • 17.4.3. By Raw Material
    • 17.4.4. By End User
    • 17.4.5. By Application
  • 17.5. Drivers and Restraints - Impact Analysis

18. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. ASEAN
      • 18.3.1.3. Oceania (Australia & New Zealand)
      • 18.3.1.4. Rest of South Asia & Pacific
    • 18.3.2. By Product Type
    • 18.3.3. By Raw Material
    • 18.3.4. By End User
    • 18.3.5. By Application
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product Type
    • 18.4.3. By Raw Material
    • 18.4.4. By End User
    • 18.4.5. By Application
  • 18.5. Drivers and Restraints - Impact Analysis

19. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Product Type
    • 19.3.3. By Raw Material
    • 19.3.4. By End User
    • 19.3.5. By Application
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product Type
    • 19.4.3. By Raw Material
    • 19.4.4. By End User
    • 19.4.5. By Application
  • 19.5. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. South Africa
      • 20.3.1.3. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Raw Material
    • 20.3.4. By End User
    • 20.3.5. By Application
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product Type
    • 20.4.3. By Raw Material
    • 20.4.4. By End User
    • 20.4.5. By Application
  • 20.5. Drivers and Restraints - Impact Analysis

21. Country Wise Softgel Capsules Market Analysis, 2024

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis, By Key Countries
    • 21.1.2. Global Vs. Country Growth Comparison
  • 21.2. U.S. Market Analysis
    • 21.2.1. By Product Type
    • 21.2.2. By Raw Material
    • 21.2.3. By End User
    • 21.2.4. By Application
  • 21.3. Canada Market Analysis
    • 21.3.1. By Product Type
    • 21.3.2. By Raw Material
    • 21.3.3. By End User
    • 21.3.4. By Application
  • 21.4. Mexico Market Analysis
    • 21.4.1. By Product Type
    • 21.4.2. By Raw Material
    • 21.4.3. By End User
    • 21.4.4. By Application
  • 21.5. Brazil Market Analysis
    • 21.5.1. By Product Type
    • 21.5.2. By Raw Material
    • 21.5.3. By End User
    • 21.5.4. By Application
  • 21.6. Germany Market Analysis
    • 21.6.1. By Product Type
    • 21.6.2. By Raw Material
    • 21.6.3. By End User
    • 21.6.4. By Application
  • 21.7. Italy Market Analysis
    • 21.7.1. By Product Type
    • 21.7.2. By Raw Material
    • 21.7.3. By End User
    • 21.7.4. By Application
  • 21.8. France Market Analysis
    • 21.8.1. By Product Type
    • 21.8.2. By Raw Material
    • 21.8.3. By End User
    • 21.8.4. By Application
  • 21.9. U.K. Market Analysis
    • 21.9.1. By Product Type
    • 21.9.2. By Raw Material
    • 21.9.3. By End User
    • 21.9.4. By Application
  • 21.10. Spain Market Analysis
    • 21.10.1. By Product Type
    • 21.10.2. By Raw Material
    • 21.10.3. By End User
    • 21.10.4. By Application
  • 21.11. Russia Market Analysis
    • 21.11.1. By Product Type
    • 21.11.2. By Raw Material
    • 21.11.3. By End User
    • 21.11.4. By Application
  • 21.12. Poland Market Analysis
    • 21.12.1. By Product Type
    • 21.12.2. By Raw Material
    • 21.12.3. By End User
    • 21.12.4. By Application
  • 21.13. China Market Analysis
    • 21.13.1. By Product Type
    • 21.13.2. By Raw Material
    • 21.13.3. By End User
    • 21.13.4. By Application
  • 21.14. Japan Market Analysis
    • 21.14.1. By Product Type
    • 21.14.2. By Raw Material
    • 21.14.3. By End User
    • 21.14.4. By Application
  • 21.15. S. Korea Market Analysis
    • 21.15.1. By Product Type
    • 21.15.2. By Raw Material
    • 21.15.3. By End User
    • 21.15.4. By Application
  • 21.16. India Softgel Capsules Market Analysis
    • 21.16.1. By Product Type
    • 21.16.2. By Raw Material
    • 21.16.3. By End User
    • 21.16.4. By Application
  • 21.17. South Africa Market Analysis
    • 21.17.1. By Product Type
    • 21.17.2. By Raw Material
    • 21.17.3. By End User
    • 21.17.4. By Application

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies (Softgel Capsules )
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Aenova Group GmbH
      • 23.3.1.1. Overview
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.1.4. Sales Footprint
      • 23.3.1.5. Strategy Overview
    • 23.3.2. Capsugel
      • 23.3.2.1. Overview
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.2.4. Sales Footprint
      • 23.3.2.5. Strategy Overview
    • 23.3.3. Guangdong Yichao Biological Co., Ltd.
      • 23.3.3.1. Overview
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.3.4. Sales Footprint
      • 23.3.3.5. Strategy Overview
    • 23.3.4. Elnova Pharma
      • 23.3.4.1. Overview
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.4.4. Sales Footprint
      • 23.3.4.5. Strategy Overview
    • 23.3.5. Hunan Er-Kang Pharmaceutical Co., Ltd
      • 23.3.5.1. Overview
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.5.4. Sales Footprint
      • 23.3.5.5. Strategy Overview
    • 23.3.6. Catalent, Inc
      • 23.3.6.1. Overview
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.6.4. Sales Footprint
      • 23.3.6.5. Strategy Overview
    • 23.3.7. Soft Gel Technologies, Inc
      • 23.3.7.1. Overview
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.7.4. Sales Footprint
      • 23.3.7.5. Strategy Overview
    • 23.3.8. Renown Pharmaceuticals
      • 23.3.8.1. Overview
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.8.4. Sales Footprint
      • 23.3.8.5. Strategy Overview
    • 23.3.9. MEDGEL
      • 23.3.9.1. Overview
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.9.4. Sales Footprint
      • 23.3.9.5. Strategy Overview
    • 23.3.10. Celix Pharma
      • 23.3.10.1. Overview
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.10.4. Sales Footprint
      • 23.3.10.5. Strategy Overview
    • 23.3.11. Roquette
      • 23.3.11.1. Overview
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.11.4. Sales Footprint
      • 23.3.11.5. Strategy Overview
    • 23.3.12. HC Clover PS
      • 23.3.12.1. Overview
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.12.4. Sales Footprint
      • 23.3.12.5. Strategy Overview
    • 23.3.13. BIONOMICS LIFESCIENCES PVT. LTD.
      • 23.3.13.1. Overview
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.13.4. Sales Footprint
      • 23.3.13.5. Strategy Overview
    • 23.3.14. Medi-Caps Group
      • 23.3.14.1. Overview
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.14.4. Sales Footprint
      • 23.3.14.5. Strategy Overview
    • 23.3.15. Others (on additional request)
      • 23.3.15.1. Overview
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.15.4. Sales Footprint
      • 23.3.15.5. Strategy Overview

24. Assumptions and Acronyms Used

25. Research Methodology